Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 SEK | +3.06% | +4.99% | -9.98% |
02-06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
02-06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 53.04M 72.44M | Sales 2025 * | 620M 56.74M 77.49M | Capitalization | 381M 34.81M 47.55M |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.56M 3.5M | Net income 2025 * | 41M 3.75M 5.12M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 77.93M 7.13M 9.74M | Net Debt 2025 * | 75.63M 6.92M 9.45M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
9.09
x | Employees | 228 |
Yield 2024 * |
2.09% | Yield 2025 * |
3.47% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | +1.43% | ||
1 week | +4.99% | ||
Current month | +1.71% | ||
1 month | +2.64% | ||
3 months | -12.02% | ||
6 months | +9.78% | ||
Current year | -9.98% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 12-31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 10.1 | +3.06% | 63 477 |
24-04-26 | 9.8 | +4.03% | 39,281 |
24-04-25 | 9.42 | -1.46% | 19,433 |
24-04-24 | 9.56 | -1.44% | 1,521 |
24-04-23 | 9.7 | +0.83% | 2,928 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 11:24 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 34.71M | |
+9.10% | 219B | |
+7.55% | 183B | |
+11.29% | 133B | |
+25.25% | 108B | |
+0.27% | 63.06B | |
+12.85% | 52.02B | |
-0.62% | 48.2B | |
+0.29% | 40.37B | |
+13.25% | 39.35B |
- Stock Market
- Equities
- BOUL Stock